Client News

Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities

Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

Abivax provides business and operational update

AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

Element Materials unveils fully integrated pharma services platform, strengthening its expanding Life Sciences Division